Impaired Fracture Healing Caused by Deficiency of the Immunoreceptor Adaptor Protein DAP12

Osteoclasts play an important role in bone metabolism, but their exact role in fracture healing remains unclear. DAP12 is an immunoadaptor protein with associated immunoreceptors on myeloid lineage cells, including osteoclasts. Its deficiency causes osteopetrosis due to suppression of osteoclast development and activation. In this report, we assessed the impact of DAP12 on the fracture healing process using C57BL/6 (B6) and DAP12–/– mice. Healing was evaluated using radiography, micro-CT, histology, immunohistochemistry and real-time RT-PCR. Radiography showed lower callus volume and lower callus radiolucency in DAP12–/– mice during later stages. Micro-CT images and quantitative structural analysis indicated that DAP12–/– mice developed calluses of dense trabecular structures and experienced deteriorated cortical shell formation on the surface. Histologically, DAP12–/– mice showed less cartilaginous resorption and woven bone formation. In addition, prominent cortical shell formation was much less in DAP12–/– mice. Immunohistochemistry revealed lower invasion of F4/80 positive monocytes and macrophages into the fracture hematoma in DAP12–/– mice. The expression levels of Col1a1, Col2a1 and Col10a1 in DAP12–/– mice increased and subsequently became higher than those in B6 mice. There was a decrease in the gene expression of Tnf during the early stages in DAP12–/– mice. Our results indicate that DAP12 deficiency impairs fracture healing, suggesting a significant role of DAP12 in the initial inflammatory response, bone remodeling and regeneration.

[1]  J. Kanis,et al.  Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  P. Kostenuik,et al.  Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. , 2012, Clinical therapeutics.

[3]  M. McDonald,et al.  Characterization of the bone phenotype and fracture repair in osteopetrotic Incisors absent rats , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  Klaus Klaushofer,et al.  Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  M. Matos,et al.  The effect of zoledronate during bone healing , 2010, Journal of Orthopaedics and Traumatology.

[6]  Thomas A Einhorn,et al.  TNF-α Mediates Diabetes-Enhanced Chondrocyte Apoptosis During Fracture Healing and Stimulates Chondrocyte Apoptosis Through FOXO1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Aaron Schindeler,et al.  Bone remodeling during fracture repair: The cellular picture. , 2008, Seminars in cell & developmental biology.

[8]  Tamara Sztynda,et al.  Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. , 2008, Bone.

[9]  R. Faccio,et al.  PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. , 2006, The Journal of clinical investigation.

[10]  Lynne E Bilston,et al.  A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[11]  Eric Vivier,et al.  KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions , 2005, European journal of immunology.

[12]  M. Ulrich-Vinther,et al.  Osteoprotegerin Treatment Impairs Remodeling and Apparent Material Properties of Callus Tissue without Influencing Structural Fracture Strength , 2005, Calcified Tissue International.

[13]  S. Komatsubara,et al.  Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. , 2005, Bone.

[14]  D. Graves,et al.  Tumor necrosis factor alpha (TNF-α) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing , 2005 .

[15]  H. Rubash,et al.  Osteoblast proliferation and maturation by bisphosphonates. , 2004, Biomaterials.

[16]  Jill A. Helms,et al.  Altered fracture repair in the absence of MMP9 , 2003, Development.

[17]  D. Graves,et al.  Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .

[18]  E. Schwarz,et al.  Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[19]  K. Väänänen,et al.  Long-Term Administration of Clodronate Does Not Prevent Fracture Healing in Rats , 2003, Clinical orthopaedics and related research.

[20]  K. Tan-Takeuchi,et al.  Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. , 2003, The Journal of clinical investigation.

[21]  M. Westmore,et al.  Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized Rats , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  S. Hayashi,et al.  Heterogeneity of presenile dementia with bone cysts (Nasu–Hakola disease):: Three genetic forms , 2002, Neurology.

[23]  L. Peltonen,et al.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.

[24]  G. Rodan,et al.  Bisphosphonate mechanism of action , 2002, Current molecular medicine.

[25]  S. Cummings,et al.  Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.

[26]  T A Einhorn,et al.  Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[28]  J. Li,et al.  Long‐Term Effect of Incadronate Disodium (YM‐175) on Fracture Healing of Femoral Shaft in Growing Rats , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  Keisuke Sato,et al.  The Role of the DAP12 Signal in Mouse Myeloid Differentiation1 , 2000, The Journal of Immunology.

[30]  Jiliang Li,et al.  Concentration of Bisphosphonate (Incadronate) in Callus Area and Its Effects on Fracture Healing in Rats , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  Leena Peltonen,et al.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.

[32]  J. Li,et al.  Effect of Bisphosphonate (Incadronate) on Fracture Healing of Long Bones in Rats , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[34]  T A Einhorn,et al.  The expression of cytokine activity by fracture callus , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[36]  E Y Chao,et al.  Internal remodeling of periosteal new bone during fracture healing , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[37]  L.,et al.  Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  D. Graves,et al.  Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. , 2005, Bone.

[39]  T A Einhorn,et al.  Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  J. Ravetch,et al.  FcR gamma chain deletion results in pleiotrophic effector cell defects. , 1994, Cell.

[41]  T. Einhorn,et al.  Production of a standard closed fracture in laboratory animal bone , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.